# Atossa Therapeutics, Inc.: Form 8-K, filed Feb 24, 2025

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 24, 2025, 21:05 ET
- Period: 2025-02-21
- Accession: 0000950170-25-025596
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/atos-20250221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000095017025025596/atos-20250221.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-025596. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.